Pharmafile Logo

Patients and data tracking

- PMLiVE

The Book of Boredom

Integrated communications might sound boring but it's a cause well worth believing in

- PMLiVE

PureTech Health appoints chief scientific officer

Dr Joseph Bolen brings 30 years of clinical experience to the biotech

- PMLiVE

Metrion Biosciences expands operations team

Dr Andrew Southan appointed head of commercial operations

Focusing on customers, not on the channels

Multichannel Excellence Conference 2016: Customer-centricity in focus

Anthill Agency

Celgene building

Celgene engages IBM Watson for patient safety work

Aims to improve its pharmacovigilance methods with a new cloud-based platform

- PMLiVE

NICE backs Eisai’s Halaven for breast cancer

Reverses 2012 rejection due to new data and patient access discount

- PMLiVE

Torrid times at Gilead lead to calls for a major M&A deal

HIV portfolio sales down almost 10% to $7.5bn despite strong $533m start for Epclusa

Immunisation politicised

The case of Human Papilloma Virus

- PMLiVE

Enterprise Therapeutics appoints CEO

Dr John Ford will lead the UK drug discovery company

- PMLiVE

NICE set to reject Merck’s Erbitux for head and neck cancer

Draft guidance rules the treatment does not provide value for money

- PMLiVE

‘Hard’ Brexit could mean a longer wait for new drugs, says report

Warns of deprioritised status if negotiators fail to secure access to the single market

- PMLiVE

Pfizer dropping bococizumab casts shadow over PCSK9 class

US payer resistance and diminishing efficacy prompt decision on would-be blockbuster

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links